Ask AI
ASCENT 04 KEYNOTE D19 PROs
ASCENT-04/KEYNOTE-D19: Patient-Reported Outcomes of 1L Sacituzumab Govitecan vs CT + Pembrolizumab in PD-L1–Positive Advanced TNBC

Released: October 28, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: October 28, 2025